Arthur F. Ryan, Director at REGENERON PHARMACEUTICALS, INC. (REGN), sold 100 shares at $827.65 ($83K) on 2023-11-07, disclosed to the SEC on 2023-11-08.
Scheduled sale ($83k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $824.59 | 6 | $5K | 6.0% |
| 2 | $825.53 | 18 | $15K | 17.9% |
| 3 | $826.58 | 4 | $3K | 4.0% |
| 4 | $827.65 | 11 | $9K | 11.0% |
| 5 | $828.54 | 39 | $32K | 39.0% |
| 6 | $829.43 | 18 |
| $15K |
| 18.0% |
| 7 | $830.39 | 3 | $2K | 3.0% |
| 8 | $838.46 | 1 | $838 | 1.0% |
| Total | $827.90 avg | 100 | $83K | 100% |
| Filing → |
| REGN | SELL | 2026-04-03 | $78K | — | Filing → |
| REGN | SELL | 2026-03-03 | $79K | — | Filing → |
| REGN | SELL | 2026-02-11 | $78K | — | Filing → |